Ohr Pharmaceuticals Cash Flow - Quarterly (NASDAQ:OHRP)

Add to My Stocks
$0.18 $0.01 (5.26%) OHRP stock closing price Sep 19, 2018 (Closing)

The Ohr Pharmaceuticals cash flow statement helps investors understand how well the company is managing its cash flows. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Ohr Pharmaceuticals profits one has to check the income statement and for Ohr Pharmaceuticals debt one has to check the balance sheet. Ohr Pharmaceuticals had cash and cash equivalents of $12.8M at beginning of the quarter and $4.44M at quarter end of 2018 Q3. Ohr Pharmaceuticals cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Ohr Pharmaceuticals has a negative cash and cash equivalents change of $-8.37M.

View and download details of Ohr Pharmaceuticals cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Oct - Sep2018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---1.16M---1.18M--
Net Increase (Decrease) in Assets Liabilities-5.33M-4.8M-1.09M1.31M1.7M2.69M-0.25M4.63M4.42M2.33M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net2.48M2.86M-2.04M1.96M1.47M1M3.95M2.86M1.73M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment--------0.01M-0.01M-0.01M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares---19.69M19.65M6.96M6.96M---
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings-0.25M-0.14M-0.1M-0.24M-0.19M-0.08M-0.08M-0.17M-0.13M-0.04M
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year12.8M12.54M28.69M13.22M5.12M2.63M----
Cash & Equivalents at Year End4.44M5.21M8.72M12.8M18.07M9.52M13.48M12.54M17.62M21.88M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Pfizer financial analysis

Ohr Pharmaceuticals stock price history provides insight into historical stock price fluctuations, and Ohr Pharmaceuticals stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Ohr Pharmaceuticals saw a negative change in Net Change in Cash and Cash Equivalents of $-8.37M till 2018 Q3. Apart from the Ohr Pharmaceuticals stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Ohr Pharmaceuticals decreased its cash from operating activities to $-8.9M till 2018 Q3. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $- for OHRP stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Ohr Pharmaceuticals spent $- from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Ohr Pharmaceuticals Cash Flow